PAVM News and Press, PAVmed Inc. From 03/29/22

Conference call to be held today at 4:30 PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health...

PAVmed (NASDAQ:PAVM) is scheduled to announce Q4 earnings results on Tuesday, March 29th, after market close. The consensus EPS Estimate is -$0.14 (-16.7% Y/Y) and the consensus Revenue Estimate is $0.46M Over the last 2 years, PAVM has beaten EPS estimates 63% of the time and has beaten reve...

Lucid Diagnostics (NASDAQ:LUCD), majority-owned unit of PAVmed (NASDAQ:PAVM), said the first patient was enrolled in a Department of Defense funded study of its EsoGuard Esophageal DNA Test in at-risk patients with gastroesophageal reflux disease (GERD). The study is being carried out by inve...

Cleveland VA enrolls first patient in DoD-funded study of EsoGuard’s impact in improving efficiency and cost-effectiveness of early detection of esophageal precancer Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage cancer prevention...

Lucid Diagnostics (NASDAQ:LUCD), a majority-owned subsidiary of PAVmed (NASDAQ:PAVM), launched Lucid Test Centers in three new metropolitan areas—Seattle, Washington; Portland, Oregon; and Boise, Idaho. The companies said that in these cities patients with chronic heartburn, also ...

Gainers: Kidpik (PIK) +79%. Eiger BioPharmaceuticals (EIGR) +42%. Mullen Automotive (MULN) +36%. Indonesia Energy (INDO) +29%. PAVmed (PAVM) +29%. Marine Petroleum (MARPS) +29%. Summer Infant (SUMR) +28%. Innodata (INOD) +27%. Houston American Energy (HUSA) +26%. Nine Energy Service (NINE) +2...

Commercial-stage med-tech firm, PAVmed (PAVM +7.1%), is trading higher after announcing the first human implants using the company’s PortIO Intraosseous Infusion System. As part of the first-in-human study in Colombia, South America, doctors at the Clinica Porto Azul in Barranquilla ha...

First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a diversified commercial-sta...

Silicon Valley luminaries, led by Apple alumnus and NeXT Computer co-founder Rich Page, to support the company’s technology development, data and analytics, and consumer engagement strategy PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified...

Company conference call and webcast at 4:30 PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ), a highly differentiated, multi-product, commercial-stage medical device company today announced that the companies will host a business update conference call on Tuesday, March 29, 202...